Search Results - "Fowkes, F Gerry"

Peripheral artery disease: epidemiology and global perspectives by Fowkes, F. Gerry R., Aboyans, Victor, Fowkes, Freya J. I., McDermott, Mary M., Sampson, Uchechukwu K. A., Criqui, Michael H.

“…Key Points The ankle–brachial index is the most appropriate measure to use in describing the global distribution of peripheral artery disease (PAD) Worldwide…”
Get full text

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease by Hiatt, William R, Fowkes, F. Gerry R, Heizer, Gretchen, Berger, Jeffrey S, Baumgartner, Iris, Held, Peter, Katona, Brian G, Mahaffey, Kenneth W, Norgren, Lars, Jones, W. Schuyler, Blomster, Juuso, Millegård, Marcus, Reist, Craig, Patel, Manesh R

“…In this randomized trial involving 13,885 patients with symptomatic peripheral artery disease (PAD), ticagrelor was not shown to be superior to clopidogrel for…”
Get full text

Measurement and Interpretation of the Ankle-Brachial Index: A Scientific Statement From the American Heart Association by ABOYANS, Victor, CRIQUI, Michael H, MARIN, Benoît, MCDERMOTT, Mary M, NORGREN, Lars, PANDE, Reena L, PREUX, Pierre-Marie, STOFFERS, H. E, TREAT-JACOBSON, Diane, ABRAHAM, Pierre, ALLISON, Matthew A, CREAGER, Mark A, DIEHM, Curt, FOWKES, F. Gerry R, HIATT, William R, JÖNSSON, Björn, LACROIX, Philippe

Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy by Bradbury, Andrew W., BSc, MD, MBA, FRCSEd, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Forbes, John F., PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Raab, Gillian M., PhD

“…Background A 2005 interim analysis of the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial showed that in patients with severe lower limb…”
Get full text

A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative by Hess, Connie N, Norgren, Lars, Ansel, Gary M, Capell, Warren H, Fletcher, John P, Fowkes, F. Gerry R, Gottsäter, Anders, Hitos, Kerry, Jaff, Michael R, Nordanstig, Joakim, Hiatt, William R

“…Peripheral artery disease affects >200 million people worldwide and is associated with significant limb and cardiovascular morbidity and mortality. Limb…”
Get full text

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease by Jones, W Schuyler, Baumgartner, Iris, Hiatt, William R, Heizer, Gretchen, Conte, Michael S, White, Christopher J, Berger, Jeffrey S, Held, Peter, Katona, Brian G, Mahaffey, Kenneth W, Norgren, Lars, Blomster, Juuso, Millegård, Marcus, Reist, Craig, Patel, Manesh R, Fowkes, F. Gerry R

“…BACKGROUND:In patients with symptomatic peripheral artery disease with a history of limb revascularization, the optimal antithrombotic regimen for long-term…”
Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received by Bradbury, Andrew W., BSc, MD, MBA, FRCSEd, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Forbes, John F., PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Raab, Gillian M., PhD

“…Background An intention-to-treat analysis of randomized Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial data showed that initial…”
Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making by Bradbury, Andrew W., BSc, MD, MBA, FRCSEd, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Forbes, John F., PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Raab, Gillian M., PhD

“…Background An intention-to-treat analysis of the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial showed that in patients with severe…”
Get full text

Association Between Raised Inflammatory Markers and Cognitive Decline in Elderly People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study by MARIONI, Riccardo E, STRACHAN, Mark W. J, MURRAY, Gordon D, DEARY, Ian J, PRICE, Jackie F, REYNOLDS, Rebecca M, LOWE, Gordon D. O, MITCHELL, Rory J, FOWKES, F. Gerry R, FRIER, Brian M, LEE, Amanda J, BUTCHERY, Isabella, RUMLEY, Ann

“…To determine whether circulating levels of the inflammatory markers C-reactive protein (CRP), interleukin (IL)-6, and tumor necrosis factor (TNF)-alpha are…”
Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis by Forbes, John F., PhD, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Raab, Gillian M., PhD, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Bradbury, Andrew W., BSc, MD, MBA, FRCSEd

“…Background The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial showed that survival in patients with severe lower limb ischemia (rest…”
Get full text

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A description of the severity and extent of disease using the Bollinger angiogram scoring method and the TransAtlantic Inter-Society Consensus II classification by Bradbury, Andrew W., BSc, MD, MBA, FRCSEd, Adam, Donald J., MD, FRCSEd, Bell, Jocelyn, PhD, Forbes, John F., PhD, Fowkes, F. Gerry R., PhD, FRCPE, Gillespie, Ian, MD, FRCR, Ruckley, Charles Vaughan, ChM, FRCSEd, CBE, Raab, Gillian M., PhD

“…Background The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial showed in patients with severe lower limb ischemia (rest pain, tissue…”
Get full text

Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial by Berger, Jeffrey S, Abramson, Beth L, Lopes, Renato D, Heizer, Gretchen, Rockhold, Frank W, Baumgartner, Iris, Fowkes, F Gerry R, Held, Peter, Katona, Brian G, Norgren, Lars, Jones, W Schuyler, Millegård, Marcus, Blomster, Juuso, Reist, Craig, Hiatt, William R, Patel, Manesh R, Mahaffey, Kenneth W

“…Patients with peripheral artery disease (PAD) are at heightened risk of cardiovascular morbidity and mortality. We sought to evaluate the risk of concomitant…”
Get full text

World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial by Norgren, Lars, North, Rebecca, Baumgartner, Iris, Berger, Jeffrey S, Blomster, Juuso I, Hiatt, William R, Jones, W Schuyler, Katona, Brian G, Mahaffey, Kenneth W, Mulder, Hillary, Patel, Manesh R, Rockhold, Frank W, Fowkes, F Gerry R

“…Regional variations exist in the epidemiology of peripheral artery disease (PAD), in comorbidities, use of secondary prevention, and outcomes. Large studies of…”
Get full text

Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial by Gutierrez, J Antonio, Mulder, Hillary, Jones, W Schuyler, Rockhold, Frank W, Baumgartner, Iris, Berger, Jeffrey S, Blomster, Juuso I, Fowkes, F Gerry R, Held, Peter, Katona, Brian G, Mahaffey, Kenneth W, Norgren, Lars, Hiatt, William R, Patel, Manesh R

“…The effect of polyvascular disease on cardiovascular outcomes in the background of peripheral artery disease (PAD) is unclear. To determine the risk of…”
Get full text

Elevated Fasting Plasma Cortisol Is Associated with Ischemic Heart Disease and Its Risk Factors in People with Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study by Reynolds, Rebecca M, Labad, Javier, Strachan, Mark W. J, Braun, Anke, Fowkes, F. Gerry R, Lee, Amanda J, Frier, Brian M, Seckl, Jonathan R, Walker, Brian R, Price, Jackie F

“…Context: Increased activity of the hypothalamic-pituitary-adrenal (HPA) axis may underlie the metabolic syndrome, but whether circulating cortisol levels…”
Get full text

Smoking, hypercholesterolaemia and hypertension as risk factors for cognitive impairment in older adults by Okusaga, Olaoluwa, Stewart, Marlene C W, Butcher, Isabella, Deary, Ian, Fowkes, F Gerry R, Price, Jackie F

“…the prevalence of all types of cognitive impairment, including dementia, is increasing but knowledge of aetiological factors is still evolving. this study…”
Get full text

Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial by Hopley, Charles W, Kavanagh, Sarah, Patel, Manesh R, Ostrom, Cara, Baumgartner, Iris, Berger, Jeffrey S, Blomster, Juuso I, Fowkes, F Gerry R, Jones, W Schuyler, Katona, Brian G, Mahaffey, Kenneth W, Norgren, Lars, Rockhold, Frank W, Hiatt, William R

“…In patients with symptomatic peripheral artery disease (PAD), the impact of chronic kidney disease (CKD) on major adverse cardiovascular events has not been…”
Get full text

Design and Rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) Trial by Berger, Jeffrey S., MD, MS, Katona, Brian G., PharmD, Jones, W. Schuyler, MD, Patel, Manesh R., MD, Norgren, Lars, MD, PhD, Baumgartner, Iris, MD, Blomster, Juuso, MD, Mahaffey, Kenneth W., MD, Held, Peter, MD, PhD, Millegård, Marcus, MSc, Heizer, Gretchen, MS, Reist, Craig, PhD, Fowkes, F. Gerry, MD, Hiatt, William R., MD

“…Abstract Background Despite overwhelming data demonstrating the efficacy of antiplatelet therapy in heart disease and stroke, data in peripheral artery disease…”
Get full text

PLA2G7 Genotype, Lipoprotein-Associated Phospholipase A2 Activity, and Coronary Heart Disease Risk in 10 494 Cases and 15 624 Controls of European Ancestry by CASAS, Juan P, NINIO, Ewa, TZOULAKI, Ioanna, KUMARI, Meena, BRUNNER, Eric J, KIVIMAKI, Mika, MARMOT, Michael G, HOFFMANN, Michael M, WINKLER, Karl, MÄRZ, Winfred, YE, Shu, STIMADEL, Heide A, PANAYIOTOU, Andrie, KHAW, Kay-Tee, HUMPHRIES, Steve E, SANDHU, Manjinder S, HINGORANI, Aroon D, TALMUD, Philippa J, PALMEN, Jutta, COOPER, Jackie A, RICKETTS, Sally L, SOFAT, Reecha, NICOLAIDES, Andrew N, CORSETTI, James P, FOWKES, F. Gerry R

“…Higher lipoprotein-associated phospholipase A(2)(Lp-PLA2) activity is associated with increased risk of coronary heart disease (CHD), making Lp-PLA2 a…”
Get full text

Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia by Marioni, Riccardo E, Stewart, Marlene C, Murray, Gordon D, Deary, Ian J, Fowkes, F Gerry R, Lowe, Gordon D O, Rumley, Ann, Price, Jackie F

“…To determine whether circulating levels of the biomarkers C-reactive protein (CRP), fibrinogen, plasma viscosity, and hematocrit were associated with cognitive…”
Get full text